Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2.
Lisa J KrügerJulian A F KleinFrank TobianMary GaeddertFederica LainatiSarah KlemmPaul SchnitzlerRalf BartenschlagerBerati CerikanChristopher J NeufeldtOlga NikolaiAndreas K LindnerFrank P MockenhauptJoachim SeyboldTerry C JonesVictor M CormanNira R PollockBritta KnorrAndreas WelkerMargaretha de VosJilian A SacksClaudia M Denkingernull nullPublished in: Infection (2021)
DRKS00021220 and 01.04.2020.